Physician profile
Manoj Patel
NPI 1184898918
$436.61
in general payments reported to CMS, 2019-2025
11 companies · $95.56 in 2025
The $95.56 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.85 · 2020: $97.92 · 2021: $128 · 2022: $13.27 · 2023: $44.57 · 2024: $42.35 · 2025: $95.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $182.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $117.92 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $115.06 | 2021 | |
| Boston Scientific Corporation | $82.55 | 2020 | |
| Novo Nordisk INC | $16.82 | 2023 | Ozempic, Rybelsus |
| Vanda Pharmaceuticals INC. | $16.56 | 2025 | Fanapt |
| Pfizer INC. | $15.87 | 2024 | |
| Allergan, INC. | $15.37 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $15.31 | 2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $14.85 | 2019 | |
| Nestle Healthcare Nutrition INC. | $13.27 | 2022 | |
| Biogen, INC. | $13.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manoj Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.